A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).

Bhatia A, Chen Z, Zhang Y, Bruce JY, Arnold S, Kaur V, Riess JW, Fenton M, Burtness B, Saba NF, Tara H, Steuer CE, Shin DM, Wasp G, Davis TH, Patel M, Schmitz JC, Bhateja P, Diavolitsis V, Zandberg DP, Mitchell DL, Kiesel BF, Kunos C, Gore SD, Carducci M, Beumer JH, Owonikoko TK

Open source

DOI: 10.1002/cncr.70346
Published: 2026 Mar 15
Container: Cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cncr.70346,
  title = {A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).},
  author = {Bhatia A and Chen Z and Zhang Y and Bruce JY and Arnold S and Kaur V and Riess JW and Fenton M and Burtness B and Saba NF and Tara H and Steuer CE and Shin DM and Wasp G and Davis TH and Patel M and Schmitz JC and Bhateja P and Diavolitsis V and Zandberg DP and Mitchell DL and Kiesel BF and Kunos C and Gore SD and Carducci M and Beumer JH and Owonikoko TK},
  year = {2026},
  journal = {Cancer},
  doi = {10.1002/cncr.70346},
  url = {https://doi.org/10.1002/cncr.70346}
}

RIS

TY  - JOUR
TI  - A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).
AU  - Bhatia A
AU  - Chen Z
AU  - Zhang Y
AU  - Bruce JY
AU  - Arnold S
AU  - Kaur V
AU  - Riess JW
AU  - Fenton M
AU  - Burtness B
AU  - Saba NF
AU  - Tara H
AU  - Steuer CE
AU  - Shin DM
AU  - Wasp G
AU  - Davis TH
AU  - Patel M
AU  - Schmitz JC
AU  - Bhateja P
AU  - Diavolitsis V
AU  - Zandberg DP
AU  - Mitchell DL
AU  - Kiesel BF
AU  - Kunos C
AU  - Gore SD
AU  - Carducci M
AU  - Beumer JH
AU  - Owonikoko TK
PY  - 2026
JO  - Cancer
DO  - 10.1002/cncr.70346
UR  - https://doi.org/10.1002/cncr.70346
ER  -

APA

A, B., Z, C., Y, Z., JY, B., S, A., V, K., JW, R., M, F., B, B., NF, S., H, T., CE, S., DM, S., G, W., TH, D., M, P., JC, S., P, B., V, D., DP, Z., DL, M., BF, K., C, K., SD, G., M, C., JH, B., & TK, O. (2026). A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).. Cancer. https://doi.org/10.1002/cncr.70346

Source records

pubmed · retrieved 2026-09-26T00:26:53.567Z